Quantitative radionuclide scanning in metabolic bone disease

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Skeletal Imaging

Background:

• Metabolic bone diseases require accurate diagnostic tools.
• Quantifying radiotracer uptake in bone can indicate disease states.
• Existing methods may lack sensitivity or specificity.

Purpose of the Study:

• To describe a simple method for quantifying skeletal uptake of 99Tcm-methylene diphosphonate.
• To present the pattern of quantified uptake in various skeletal regions and organs.
• To evaluate the method's ability to distinguish metabolic bone disease patients from controls.

Main Methods:

• Utilized a rectilinear scanner and a simultaneously imaged standard for quantification.
• Analyzed tracer uptake in ten skeletal regions, sacroiliac joints, and kidneys.
• Compared uptake patterns in 57 controls and 54 patients with metabolic bone disease.

Main Results:

• The method effectively distinguished primary hyperparathyroidism and osteomalacia from controls.
• Increased skull uptake in primary hyperparathyroidism correlated with biochemical markers and bone resorption.
• Osteoporosis showed normal to moderate skull uptake, correlating with bone density.
• Osteomalacia demonstrated the highest skull uptake.
• Thyrotoxicosis presented with increased uptake in long bone shafts.

Conclusions:

• The quantitative bone uptake method is a sensitive, noninvasive test for detecting metabolic bone disease.
• This technique can be valuable for monitoring therapeutic responses in bone diseases.